Dossier
mRNA influenza vaccine
Coverage of mRNA influenza vaccine in the Nexus archive.
- FDA committee unanimously recommends first mRNA flu vaccine
The Food and Drug Administration's top vaccine advisory committee unanimously recommended the first mRNA influenza vaccine. It uses the same technology as the COVID-19 shots.
- Key FDA committee unanimously recommends its first vaccine since 2023
A key FDA committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over. The recommendation marks the committee's first vaccine approval since 2023.
- Key FDA committee unanimously recommends its first vaccine since 2023
A key FDA committee unanimously recommended Moderna's new mRNA influenza vaccine for adults aged 50 and over. All nine committee members voted in favor of the recommendation.